Evagrace Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 100.55%
- Profit Growth 32.12%
- Ebitda 34.52%
- Net Worth 44.72%
- Total Assets 50.53%
About Evagrace Pharma
Evagrace Pharma Private Limited (EPPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 November 2018 (Six years and two months 5 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Samir Shah, Ronak Shah, Khushboo Shah, and Three other members serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U51909GJ2018PTC105415
-
Company No.
105415
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Nov 2018
-
Date of AGM
17 Jul 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Evagrace Pharma?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samir Shah
|
Director | 12-Nov-2021 | Current |
|
Ronak Shah
|
Director | 30-Nov-2018 | Current |
|
Khushboo Shah
|
Director | 30-Nov-2018 | Current |
|
Krushant Parekh
|
Director | 17-Jul-2023 | Current |
|
Pavankumar Varma
|
Director | 17-Jul-2023 | Current |
|
Yogendra Rathod
|
Director | 17-Jul-2023 | Current |
Financial Performance of Evagrace Pharma.
Evagrace Pharma Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 100.55% increase. The company also saw a substantial improvement in profitability, with a 32.12% increase in profit. The company's net worth Soared by an impressive increase of 44.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Evagrace Pharma?
In 2024, Evagrace Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Medico Intercontinental LimitedSamir Shah is a mutual person
-
Kingston Club & Spa Private LimitedSamir Shah is a mutual person
-
Azillian Healthcare Private LimitedSamir Shah is a mutual person
-
Kings Marvela LlpSamir Shah is a mutual person
-
Sungrace Pharma Private Limited
Samir Shah and Ronak Shah are mutual person
-
Ritz Formulations Private Limited
Samir Shah is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Evagrace Pharma?
Evagrace Pharma has a workforce of 11 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Evagrace Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Evagrace Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.